Bank of America
INZY

Bank of America’s Inozyme Pharma INZY Stock Holding History

Bank of America’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,000
Closed -$21.3K – 7951
2023
Q4 		$21.3K Hold
5,000
– – ﹤0.01% 6776
2023
Q3 		$21K Buy
+5,000
New +$25.4K ﹤0.01% 6701

Bank of America's INZY Position: Q3 2025 in Review

Bank of America sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 52,454 shares — an estimated $210K sold.

Bank of America first reported a position in INZY in Q3 2020 and held it in 20 quarters. The position peaked at $636K in Q3 2024. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • Bank of America reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 52,454 Inozyme Pharma shares in Q3 2025, an estimated $210K.
  • Bank of America first reported a position in Inozyme Pharma in Q3 2020 and held it in 20 quarters.
  • Bank of America's Inozyme Pharma position peaked at $636K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.